57 research outputs found

    Effect of change of BMI between t<sub>0–5</sub> and t<sub>0–5</sub>+ t<sub>5–10</sub> on all cause-mortality in men stratified for baseline BMI: VHM&PP Study Cohort 1985–2009.

    Full text link
    <p>change of BMI (<−0.10 kg/m<sup>2</sup>/year, −0.10–0.09 kg/m<sup>2</sup>/year, ≥0.10 kg/m<sup>2</sup>/year) between baseline and year 5 (t<sub>0–5</sub>) and between year 5 and 10 (t<sub>5–10</sub>).</p><p>Hazard rate ratio (HR) and 95% confidence interval (95% CI) adjusted for smoking status and stratified for age.</p><p><sup>#</sup> reference category.</p

    Additional file 1: Table S1. of Changes in life expectancy 1950–2010: contributions from age- and disease-specific mortality in selected countries

    Full text link
    Relative change in life expectancy [years] by 5-year interval in women according to cause of death*. Table S2 Relative change in life expectancy [years] by 5-year interval in men according to cause of death*. Table S3 Relative change in life expectancy [years] by 5-year interval in women according to age of death*. Table S4 Relative change in life expectancy [years] by 5-year interval in men according to age of death*. (DOCX 481 kb

    Effect of change of BMI between t<sub>0–5</sub> and t<sub>0–5</sub>+ t<sub>5–10</sub> on all cause-mortality in women stratified for baseline BMI: VHM&PP Study Cohort 1985–2009.

    Full text link
    <p>change of BMI (<−0.10 kg/m<sup>2</sup>/year, −0.10–0.09 kg/m<sup>2</sup>/year, ≥0.10 kg/m<sup>2</sup>/year) between baseline and year 5 (t<sub>0–5</sub>) and between year 5 and 10 (t<sub>5–10</sub>).</p><p>Hazard rate ratio (HR) and 95% confidence interval (95% CI) adjusted for smoking status and stratified for age.</p><p><sup>#</sup> reference category.</p

    Effect of different patterns of BMI at t<sub>0</sub>, t<sub>5</sub>, and t<sub>10</sub> on all cause-mortality among men and women in the VHM&PP Study Cohort 1985–2009.

    Full text link
    <p>Effect of different patterns of BMI at t<sub>0</sub>, t<sub>5</sub>, and t<sub>10</sub> on all cause-mortality among men and women in the VHM&PP Study Cohort 1985–2009.</p

    Baseline (t0) and 10-year follow-up (t1) prevalence of impaired fasting glucose and diabetes by baseline BMI category.

    Full text link
    <p>Baseline (t0) and 10-year follow-up (t1) prevalence of impaired fasting glucose and diabetes by baseline BMI category.</p

    Characteristics of the study population at baseline and 10-year follow-up.

    Full text link
    <p><i>BMI</i> body mass index, <i>MAP</i> mean arterial pressure, <i>FG</i> fasting glucose, <i>TC</i> total cholesterol, <i>TG</i> triglycerides, <i>ɣ-GT</i> γ-glutamyltransferase</p><p>Characteristics of the study population at baseline and 10-year follow-up.</p

    Changes in BMI category over 10 years.

    Full text link
    <p><sup>a</sup> Given percentages sum up to 100 within rows</p><p>Changes in BMI category over 10 years.</p
    • …
    corecore